- Imprimis Pharmaceuticals (NASDAQ:IMMY-OLD): Q1 EPS of -$0.26 misses by $0.07.
- Revenue of $6.1M (+39.3% Y/Y) misses by $0.4M.
- Press Release
Imprimis Pharmaceuticals misses by $0.07, misses on revenue
Recommended For You
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
IMMY-OLD | - | - |
Imprimis Pharmaceuticals, Inc. |